Phibro Animal Health Corporation (PAHC) News
Follow Phibro Animal Health Corporation (PAHC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 18 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Phibro Animal Health to participate in Morgan Stanley Annual Global Healthcare Conference
EQUITY | Sep 09, 2026, 08:30 PM UTC
L
PAHC: Record sales and EBITDA growth in 2026 set the stage for continued expansion in 2027
PAHC: Record sales and EBITDA growth in 2026 set the stage for continued expansion in 2027
EQUITY | Aug 27, 2026, 03:22 PM UTC
L
PAHC reports record sales and EBITDA growth; guides FY 2027
PAHC said it delivered record sales and EBITDA growth and set prudent FY 2027 guidance amid regulatory uncertainty.
EARNINGS | Aug 27, 2026, 03:00 PM UTC
L
Phibro raises fiscal 2027 sales, EBITDA guidance after record year
Phibro Animal Health reported record fiscal 2026 net sales of more than $1.5 billion and 39% growth in adjusted EBITDA, then guided fiscal 2027 sales to $1.55 billion-$1.6 billion and adjusted EBITDA to $258 million-$268
EARNINGS | Aug 27, 2026, 01:47 PM UTC
L
PAHC cites strong sales, EBITDA growth; positive FY2027 outlook
PAHC reports strong sales and EBITDA growth driven by Animal Health, and a positive FY2027 outlook.
EARNINGS | Aug 27, 2026, 12:50 PM UTC
L
Phibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
Phibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
EARNINGS | Aug 26, 2026, 10:17 PM UTC
L
Phibro Transformation Program Initiatives Fuel Ebitda Gains — Company Talk
Phibro Transformation Program Initiatives Fuel Ebitda Gains — Company Talk
EQUITY | Aug 26, 2026, 09:02 PM UTC
L
Phibro Offers Conservative FY27 Estimates — Company Talk
Phibro Offers Conservative FY27 Estimates — Company Talk
EQUITY | Aug 26, 2026, 08:59 PM UTC
L
PAHC plans to close Chicago Heights plant
PAHC plans to close its Chicago Heights manufacturing plant as it consolidates its manufacturing network.
EQUITY | Aug 26, 2026, 08:54 PM UTC
L
PAHC expects continued expansion in FY27 after FY26 growth
PAHC reported record sales and profit growth in FY26 and expects continued expansion in FY27.
EARNINGS | Aug 26, 2026, 08:38 PM UTC
L
Phibro Animal Health FY 2026 revenue, EPS reported
Phibro Animal Health reported FY 2026 revenue of $1.52 billion and EPS of $2.43 in a 10-K summary.
EARNINGS | Aug 26, 2026, 08:37 PM UTC
L
Phibro Animal reports FY26 revenue $1.518B, adj. EBITDA $255M
FY26 revenue was $1.518B and adjusted EBITDA was $255M. Q4 sales were $396.7M.
EARNINGS | Aug 26, 2026, 08:34 PM UTC
L
Phibro Animal Health Q4 results beat estimates
Phibro Animal Health reported Q4 results that beat estimates, citing mineral nutrition growth.
EARNINGS | Aug 26, 2026, 08:32 PM UTC
H
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
EQUITY | Aug 26, 2026, 08:23 PM UTC
L
Phibro Animal Health reports 4Q EPS 53c
Phibro Animal Health posted 4Q EPS of 53c.
EARNINGS | Aug 26, 2026, 08:22 PM UTC
L
Phibro Animal Health Q4 adjusted EPS $0.85 vs $0.71 est
Phibro Animal Health reported Q4 adjusted EPS of $0.85 versus an IBES estimate of $0.71.
EARNINGS | Aug 26, 2026, 08:21 PM UTC
L
PAHC reports FY2026 net sales up 17% to $1.52B
PAHC says FY2026 net sales rose 17% to $1.52B. Net income rose 107% with margin expansion, per TradingView News.
EARNINGS | Aug 26, 2026, 08:20 PM UTC
M
PAHC Appoints CEO
Phibro Animal Health appoints Daniel Bendheim as CEO and President effective July 1, 2026
EQUITY | Jun 26, 2026, 09:12 PM UTC